LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Return
10.14%
This Quarter Return
-15.38%
1 Year Return
+10.14%
3 Year Return
+35.76%
5 Year Return
+141%
10 Year Return
–
AUM
$605M
AUM Growth
-$43.1M
(-6.6%)
Cap. Flow
+$64.2M
Cap. Flow
% of AUM
10.61%
Top 10 Holdings %
Top 10 Hldgs %
48.94%
Holding
2,935
New
350
Increased
1,175
Reduced
756
Closed
208
Top Buys
| 1 |
Golub Capital BDC
GBDC
|
+$23.6M |
| 2 |
Oaktree Specialty Lending
OCSL
|
+$11.8M |
| 3 |
Microsoft
MSFT
|
+$3.22M |
| 4 |
Apple
AAPL
|
+$3.05M |
| 5 |
RPAR Risk Parity ETF
RPAR
|
+$1.9M |
Top Sells
| 1 |
Digital Turbine
APPS
|
+$2.38M |
| 2 |
Blackstone Mortgage Trust
BXMT
|
+$1.84M |
| 3 |
Nuveen S&P 500 Buy-Write Income Fund
BXMX
|
+$1.69M |
| 4 |
DBGI
Digital Brands Group, Inc. Common Stock
DBGI
|
+$1.37M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$1.06M |
Sector Composition
| 1 | Financials | 18.89% |
| 2 | Technology | 11.63% |
| 3 | Healthcare | 5.08% |
| 4 | Consumer Discretionary | 3.93% |
| 5 | Energy | 3.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Mercer International
MERC
$206M
| $2K | ﹤0.01% |
123
| – | – |
|
1977
M/I Homes
MHO
$4.07B
| $2K | ﹤0.01% |
46
+5
| +12% | +$217 |
|
1978
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$13.8B
| $2K | ﹤0.01% |
+20
| New | +$2K |
|
1979
Mercury Systems
MRCY
$4.34B
| $2K | ﹤0.01% |
25
| – | – |
|
1980
Marten Transport
MRTN
$953M
| $2K | ﹤0.01% |
139
+39
| +39% | +$561 |
|
1981
Vail Resorts
MTN
$5.33B
| $2K | ﹤0.01% |
7
+3
| +75% | +$857 |
|
1982
Navient
NAVI
$1.28B
| $2K | ﹤0.01% |
153
-46
| -23% | -$601 |
|
1983
Nordson
NDSN
$12.5B
| $2K | ﹤0.01% |
11
-13
| -54% | -$2.36K |
|
1984
Ingevity
NGVT
$2.12B
| $2K | ﹤0.01% |
28
-24
| -46% | -$1.71K |
|
1985
Nkarta
NKTX
$140M
| $2K | ﹤0.01% |
200
+17
| +9% | +$170 |
|
1986
New Mountain Finance
NMFC
$1.11B
| $2K | ﹤0.01% |
200
| – | – |
|
1987
Rogers Corp
ROG
$1.47B
| $2K | ﹤0.01% |
6
+2
| +50% | +$667 |
|
1988
Ryerson Holding
RYI
$723M
| $2K | ﹤0.01% |
80
+10
| +14% | +$250 |
|
1989
Cassava Sciences
SAVA
$102M
| $2K | ﹤0.01% |
79
+38
| +93% | +$962 |
|
1990
Agios Pharmaceuticals
AGIO
$2.14B
| $2K | ﹤0.01% |
74
+63
| +573% | +$1.7K |
|
1991
AdaptHealth
AHCO
$1.26B
| $2K | ﹤0.01% |
+125
| New | +$2K |
|
|
AIV
1992
Aimco
AIV
$1.07B
| $2K | ﹤0.01% |
269
+54
| +25% | +$401 |
|
1993
Acadia Realty Trust
AKR
$2.64B
| $2K | ﹤0.01% |
129
+97
| +303% | +$1.5K |
|
1994
Alector
ALEC
$278M
| $2K | ﹤0.01% |
+183
| New | +$2K |
|
1995
Autoliv
ALV
$9.68B
| $2K | ﹤0.01% |
26
-9
| -26% | -$692 |
|
1996
ALX Oncology
ALXO
$56.8M
| $2K | ﹤0.01% |
215
+81
| +60% | +$753 |
|
1997
Amneal Pharmaceuticals
AMRX
$3.14B
| $2K | ﹤0.01% |
703
+539
| +329% | +$1.53K |
|
1998
Atara Biotherapeutics
ATRA
$85.1M
| $2K | ﹤0.01% |
+10
| New | +$2K |
|
1999
Health Catalyst
HCAT
$220M
| $2K | ﹤0.01% |
+128
| New | +$2K |
|
2000
Houlihan Lokey
HLI
$14.4B
| $2K | ﹤0.01% |
23
+9
| +64% | +$783 |
|